Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)
ClinicalTrials.gov, 14 Jan 2014
Accessed on 30 Jan 2014 from http://www.clinicaltrials.gov/ct2/show/NCT01212094.